Last reviewed · How we verify
Menazone (furonazide)
Menazone (generic name: furonazide) is a furonazide drug. It is currently in unknown development.
Menazone works by binding to and altering the activity of a specific biological molecule.
Menazone, also known as furonazide, is a crystalline substance with a melting point of 199-201.5°C. It is used as a tuberculostatic drug.
At a glance
| Generic name | furonazide |
|---|---|
| Drug class | furonazide |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells are like a city, and the biological molecules are like the traffic lights that control the flow of information. Menazone is like a traffic cop that changes the way the lights work, allowing the city to function differently. This can help to treat certain diseases by changing the way the cells communicate and behave.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Menazone CI brief — competitive landscape report
- Menazone updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Menazone
What is Menazone?
How does Menazone work?
What is the generic name of Menazone?
What drug class is Menazone in?
What development phase is Menazone in?
Related
- Drug class: All furonazide drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing